Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-02-23 @ 3:01 PM
Study NCT ID:
NCT00907803
Status:
COMPLETED
Last Update Posted:
2010-09-21
First Post:
2009-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246
Sponsor:
SIGA Technologies
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SIGA-246-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Annie Frimm, Vice President Regulatory Affairs
Old Organization:
SIGA Technologies, Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |